Back to the main directory
EarningsReview / Equity
- Roadshow feedback -Cunliffe’s support of sector investability in focus by BNP Paribas
- On the road with Kingfisher by BNP Paribas
- Thoughts ahead of FY results & CMD by BNP Paribas
- Tirlan proposed secondary placing by BNP Paribas
- CMD feedback: credibility added to medium term targets by BNP Paribas
- Thoughts ahead of Q3 results & the November CMD by BNP Paribas
- SaaSk Us Anything: Who’s hiring and who’s selling? August Edition by BNP Paribas
- TrumpRx provides a win-win situation for Pharma? by BNP Paribas
- Ready to pounce by BNP Paribas
- Q3’25 preview: getting back up after a Summer knock-down by BNP Paribas
- BTM Islands & The Tower of Babel by BNP Paribas
- Inflection not yet in sight: we see +5.9%cc org growth for FY26 by BNP Paribas
- Q3’25 preview: growth dot-plot the centre of attention by BNP Paribas
- Izertis - 1H25: Profitable growth continues; Buy by JB Capital Markets
- Feedback from company contact by BNP Paribas
- Talgo - Feeling the pain despite glimmers of hope on the backlog by JB Capital Markets
- Hochtief’s data centre exposure, air traffic, air cargo, easyJet, Lufthansa, FedEx/ UPS, Aena, Eiffage, ACS by BNP Paribas
- TALGO: RDOS. 1S’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- Affluent Medical - En ligne by MidCap Partners
- Portobello - Un S1 à l’arrêt et sans levée du concordat juridique by MidCap Partners
- ICAPE HOLDING - Vigoureux redressement de la rentabilité by MidCap Partners
- Novamarine S.p.A. - Un S1 robuste, trajectoire confirmée pour 2025 by MidCap Partners
- Racing Force - DOUBLE-DIGIT ORDER INTAKE DRIVES CONFIDENCE ON FY GROWTH by Equita Sim
- TALGO: 1H’25 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Novamarine S.p.A. - A Robust H1, Trajectory Confirmed for 2025 by MidCap Partners